During the past decade, Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc." are "Alzheimer's Disease" (2 trials) and "Treatment Resistant Depression" (1 trials). Many other conditions were trialed in "Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc." in a lesser frequency.

Most popular intervention types in "Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Aducanumab" (2 trials), "Placebo" (2 trials) and "Liafensine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".